Originally graduating with a major in medicinal chemistry from Monash University, Jackson has shifted his interests into bridging the gap between molecule and cell. His research interest includes screening small molecule-based therapeutics against epigenetic cancer targets. His doctoral research focuses on investigating the effectivity of multi-functional small molecules for future clinical applications.